Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Steven M. Keller, MD
lungcanc
Robert J. Cerfolio, MD, MBA
lungcanc
Role of Molecular Testing for AHCP Caring for Patients with NSCLC
lungcanc
ELCC 2017 Unveils New Research Regarding Screening, Immunotherapy, Treatment Planning, and...
lungcanc
Clinical Labeling in Medicinal Products: An Interview With Dr. David Planchard...
lungcanc
IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer
lungcanc
IASLC Thoracic Oncology (2nd ed.)
lungcanc
NCI Corner – Interview with Matthew Holderfield, PhD
lungcanc
Breaking News Briefs
lungcanc
Deb Violette, Lung Cancer Survivor and Advocate: Her Story
lungcanc
1
...
36
37
38
...
53
Page 37 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
